arrow
J

Julius Keyl

Institute for Artificial Intelligence in Medicine
H指数:10
被引数:494

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OncoVR - Virtual Reality in Oncology for Patient-centered Care: A Systematic Review and Meta-Analysis

OncoVR - 虚拟现实在肿瘤学中的以患者为中心的护理:一项系统评价和Meta分析

2026-03-260
OAAI
Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease; heart failure; or kidney disease: real-world evidence from a German University Hospital

在2型糖尿病合并心血管疾病;心力衰竭;或肾脏疾病患者中实施指南推荐的器官保护性治疗:来自德国大学医院的真实世界证据

2026-01-060
OAAI
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆

胆道癌中生物标志物检测的临床实践与意义:一项观察性研究☆

2025-11-040
OAAI
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification

利用自动CT体成分分析杠杆化肌肉减少症指数,用于泛癌种预后分层。

2025-10-140
OA
Early Years, Advanced Disease: The Unmet Need in Young Adults with Non-Small Cell Lung Cancer

早年,晚期疾病:非小细胞肺癌年轻成年患者中的未满足需求

2025-09-240
OAAI
Establishing Medical Intelligence-Leveraging Fast HealthcareInteroperability Resources to Improve Clinical Management:Retrospective Cohort and Clinical Implementation Study
2024-10-310
OA
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome

寡转移非小细胞肺癌: 局部和当代系统治疗方法对临床结果的影响

2024-09-254
OAAI
Prognostic value of deep learning-derived body composition in advanced pancreatic cancerda retrospective multicenter study
2024-01-014
OAAI
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma

双特异性抗体重定向合成激动性受体修饰的T细胞抗黑色素瘤

2023-05-194
OAAI
Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor - Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models

靶向间皮素的双特异性抗体驱动合成激动性受体转导的T细胞介导人类胰腺癌模型的特异性和条件性治疗

2018-03-010
PREAI